Institutional & Family Asset Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$83.14 - $145.99 $665 - $1,167	-8 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$98.85 - $138.91 $494 - $694	-5 Reduced 38.46%	8 $1,000
Q1 2021 May 06, 2021	SELL	$64.07 - $91.75 $512 - $734	-8 Reduced 38.1%	13 $1,000
Q4 2020 Feb 03, 2021	SELL	$65.07 - $98.24 $65 - $98	-1 Reduced 4.55%	21 $2,000
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $203 - $519	-7 Reduced 24.14%	22 $2,000
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $531 - $749	-13 Reduced 30.95%	29 $2,000
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $37 - $49	1 Added 2.44%	42 $2,000
Q3 2018 Nov 13, 2018	SELL	$32.79 - $43.0 $229 - $301	-7 Reduced 14.58%	41 $2,000
Q1 2018 May 14, 2018	BUY	$22.49 - $34.56 $1,079 - $1,658	48 New	48 $1,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account